Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of British Columbia
$120,000.00
Biologics during Pregnancy in Arthritis Patients: Patterns of Use and Perinatal Outcomes
FY 2025-26
Summary
Arthritis is a group of diseases that causes joint pain, stiffness, and swelling, and it often affects females during their childbearing years. To manage symptoms and keep the disease under control, strong medications are used. In recent decades, a new, innovative group of arthritis drugs named biologics have become available and are very effective for treating arthritis diseases. Since then, although we are starting to see biologics may be safe to use during pregnancy, research shows that many patients still stop taking them at first sign of pregnancy. This is a concern because when these diseases are not properly kept under control during pregnancy, it leads to harm in moms and babies. However, it is not known whether stopping or continuing biologics during pregnancy is better-or safer-for both moms and babies. This creates uncertainty when doctors and patients are making treatment decisions or family planning. To solve this problem, I will use big (i.e., large-scale) healthcare data on the entire population of British Columbia to discover whether stopping or continuing biologics during pregnancy causes harm on the health of mothers and their babies. My findings will provide much-needed answers to help doctors and patients make better, safer decisions during family planning and pregnancy.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560051
Name
Cheng Vienna
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Biologics during Pregnancy in Arthritis Patients: Patterns of Use and Perinatal Outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Biologics; Disease-Modifying Antirheumatic Drugs; Epidemiology; Health Outcomes; Inflammatory Arthritis; Maternal; Neonatal; Pregnancy; Quantitative Research
Abstract
Arthritis is a group of diseases that causes joint pain, stiffness, and swelling, and it often affects females during their childbearing years. To manage symptoms and keep the disease under control, strong medications are used. In recent decades, a new, innovative group of arthritis drugs named biologics have become available and are very effective for treating arthritis diseases. Since then, although we are starting to see biologics may be safe to use during pregnancy, research shows that many patients still stop taking them at first sign of pregnancy. This is a concern because when these diseases are not properly kept under control during pregnancy, it leads to harm in moms and babies. However, it is not known whether stopping or continuing biologics during pregnancy is better-or safer-for both moms and babies. This creates uncertainty when doctors and patients are making treatment decisions or family planning. To solve this problem, I will use big (i.e., large-scale) healthcare data on the entire population of British Columbia to discover whether stopping or continuing biologics during pregnancy causes harm on the health of mothers and their babies. My findings will provide much-needed answers to help doctors and patients make better, safer decisions during family planning and pregnancy.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cheng, Vienna
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~